Mingjun Chen
Impact in
-
- Cancer, Lipids, and Metabolism
Papers in
-
- Peroxisome Proliferator-Activated Receptors 2
-
- Ferroptosis and cancer prognosis 2
- Co-authors
- Yongzhong Hou (4 shared papers)Juanjuan Shi (2 shared papers)Yuhan Wang (1 shared paper)Jianbo Xiao (2 shared papers)Chao Zhao (2 shared papers)Chengfeng Yang (2 shared papers)Bin Liu (2 shared papers)Huiqing Chen (2 shared papers)
- Journals
- Medicine (2 papers)Evidence-based Complementary and Alternative Medicine (2 papers)Frontiers in Pharmacology (1 paper)Cell Death Discovery (1 paper)Journal of Pharmaceutical and Biomedical Analysis (1 paper)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Mingjun Chen
20 papers receiving 440 citations
Peers
Comparison fields: 5 of 83
- Health Informatics 7
- Cancer Research 51
- Rehabilitation 20
- Pulmonary and Respiratory Medicine 92
- Complementary and alternative medicine 24
Countries citing papers authored by Mingjun Chen
This map shows the geographic impact of Mingjun Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingjun Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingjun Chen more than expected).
Fields of papers citing papers by Mingjun Chen
This network shows the impact of papers produced by Mingjun Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingjun Chen. The network helps show where Mingjun Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Mingjun Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 116 | |
| 2 | 2020 | 83 | |
| 3 | 2017 | 60 | |
| 4 | 2010 | 44 | |
| 5 | 2018 | 31 | |
| 6 | 2023 | 20 | |
| 7 | 2023 | 19 | |
| 8 | 2020 | 19 | |
| 9 | 2022 | 13 | |
| 10 | 2024 | 7 | |
| 11 | 2019 | 5 | |
| 12 | 2023 | 5 | |
| 13 | 2023 | 5 | |
| 14 | [Risk factors and clinical outcomes of nosocomial infections caused by multidrug resistant Pseudomonas aeruginosa]. | 2004 | 4 |
| 15 | 2017 | 4 | |
| 16 | 2025 | 3 | |
| 17 | 2018 | 2 | |
| 18 | 2018 | 2 | |
| 19 | 2020 | 1 | |
| 20 | 2017 | 1 |
About Mingjun Chen
Mingjun Chen is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Complementary and alternative medicine, Endocrinology, Diabetes and Metabolism and Pharmacology, having authored 20 papers that have together received 444 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (2 papers), Immune cells in cancer (2 papers), Peroxisome Proliferator-Activated Receptors (2 papers), Seaweed-derived Bioactive Compounds (2 papers), Autophagy in Disease and Therapy (2 papers), Diabetic Foot Ulcer Assessment and Management (2 papers), Recycling and Waste Management Techniques (1 paper) and Body Composition Measurement Techniques (1 paper). The work is most often cited by research in Health Informatics (7 citations), Cancer Research (51 citations), Rehabilitation (20 citations), Pulmonary and Respiratory Medicine (92 citations) and Complementary and alternative medicine (24 citations). Mingjun Chen has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Yongzhong Hou, Juanjuan Shi, Yuhan Wang, Jianbo Xiao, Chao Zhao, Chengfeng Yang, Bin Liu, Huiqing Chen, Qian Gou and Juanjuan Shi. Their work appears in journals such as Medicine, Evidence-based Complementary and Alternative Medicine, Frontiers in Pharmacology, Cell Death Discovery and Journal of Pharmaceutical and Biomedical Analysis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.